Summary
Moderna and Merck are expected to share the Phase 3 data for their experimental cancer vaccine this weekend at a medical conference.
Moderna and Merck are expected to share the Phase 3 data for their experimental cancer vaccine this weekend at a medical conference.
Source & full coverage: this summary is aggregated from MarketWatch, the original publisher. Read the complete report for full context, data and quotes.
Read the original report at MarketWatch →